The name of a hormone does not fully describe every historical preparation. This small report included laboratory findings that complicate a simple hCG-only interpretation. Primary study
What was observed
Three men with gonadotropin deficiency received prolonged hCG treatment. Sperm appeared in two, then disappeared after withdrawal. The authors also found FSH-like activity from the crude preparation in a rat Sertoli-cell assay. Primary report
Our appraisal: follow the preparation as well as the label
A biological preparation can have activities that are not captured by a simplified product name. If an assay detects additional activity, attributing every clinical observation exclusively to one intended hormonal action becomes more difficult.
That does not identify the precise cause of the additional activity or prove that it drove the clinical response. Those are separate questions. It does mean that the preparation's characterization belongs in the interpretation and that the result should not be transferred automatically to a modern purified or recombinant product.
Withdrawal observations add useful temporal information, but they are not a randomized withdrawal trial. A change after stopping treatment can support dependence on continued exposure while still leaving uncertainty about mechanisms and alternative influences.
The sample size is an equally important boundary. Two responses among three patients cannot provide a stable population success rate. Long observation of a few individuals gives detailed clinical histories, not broad precision.
This historical study is valuable for understanding why formulation identity and endocrine endpoints must be kept explicit. It does not establish that hCG alone is sufficient for every form of hormone-deficiency infertility or that different preparations are interchangeable. A publication-ready account should inspect the original product characterization, patient histories, and assay specificity while clearly presenting the report as a small observational series.
Frequently asked questions
How many patients were described?
Three.
Did sperm appear in every patient?
No, in two.
Was withdrawal followed by loss of the sperm response?
Yes, as reported.
Was additional biological activity detected in the preparation?
An FSH-like signal was reported in a cell assay.
Does that identify the exact clinical mechanism?
No.
Can this establish a precise population response rate?
No.
What is the main historical lesson?
Preparation-specific activity matters when transferring evidence between products.